| MeSH term | MeSH ID | Detail |
|---|---|---|
| Diabetic Nephropathies | D003928 | 39 associated lipids |
| Diabetic Neuropathies | D003929 | 5 associated lipids |
| Diarrhea | D003967 | 32 associated lipids |
| Dilatation, Pathologic | D004108 | 5 associated lipids |
| Disease Susceptibility | D004198 | 12 associated lipids |
| Emphysema | D004646 | 1 associated lipids |
| Encephalitis | D004660 | 15 associated lipids |
| Endocrine System Diseases | D004700 | 4 associated lipids |
| Endometriosis | D004715 | 29 associated lipids |
| Eye Neoplasms | D005134 | 2 associated lipids |
7-octadecynoic acid
7-octadecynoic acid is a lipid of Fatty Acyls (FA) class.
Cross Reference
There are no associated biomedical information in the current reference collection.
Current reference collection contains 19785 references associated with 7-octadecynoic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.
Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.
Here are additional resources we collected from PubChem and MeSH for 7-octadecynoic acid
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with 7-octadecynoic acid
All references with 7-octadecynoic acid
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Wang Y et al. | LC, a novel estrone-rhein hybrid compound, concurrently stimulates osteoprotegerin and inhibits receptor activator of NF-κB ligand (RANKL) and interleukin-6 production by human osteoblastic cells. | 2011 | Mol. Cell. Endocrinol. | pmid:21291955 |
| Szulc P et al. | Cortical bone status is associated with serum osteoprotegerin concentration in men: the STRAMBO study. | 2011 | J. Clin. Endocrinol. Metab. | pmid:21565793 |
| Zhang M et al. | EP1(-/-) mice have enhanced osteoblast differentiation and accelerated fracture repair. | 2011 | J. Bone Miner. Res. | pmid:20939055 |
| Millard SM et al. | Blockade of receptor-activated G(i) signaling in osteoblasts in vivo leads to site-specific increases in cortical and cancellous bone formation. | 2011 | J. Bone Miner. Res. | pmid:20939063 |
| Reinhard H et al. | Osteoprotegerin and coronary artery disease in type 2 diabetic patients with microalbuminuria. | 2011 | Cardiovasc Diabetol | pmid:21801376 |
| Gordon IK and Camphausen K | Research highlights. | 2011 | Biomark Med | pmid:21861664 |
| Jabbar S et al. | Plasma vitamin D and cytokines in periodontal disease and postmenopausal osteoporosis. | 2011 | J. Periodont. Res. | pmid:20731767 |
| Malliga DE et al. | The role of osteoprotegerin (OPG) receptor activator for nuclear factor kappaB ligand (RANKL) in cardiovascular pathology - a review. | 2011 | Wien Med Wochenschr | pmid:21870142 |
| Guo HL et al. | [Experimental study on the mechanism of icariin improving human osteoblasts proliferation and the expression of OPG protein]. | 2011 | Zhongguo Gu Shang | pmid:21870401 |
| McGrath EE | OPG/RANKL/RANK pathway as a therapeutic target in cancer. | 2011 | J Thorac Oncol | pmid:21849854 |
| Findlay DM and Atkins GJ | Relationship between serum RANKL and RANKL in bone. | 2011 | Osteoporos Int | pmid:21850548 |
| Harada S and Takahashi N | [Control of bone resorption by RANKL-RANK system]. | 2011 | Clin Calcium | pmid:21814016 |
| Nakamura M and Udagawa N | [Osteoporosis and RANKL signal]. | 2011 | Clin Calcium | pmid:21814019 |
| Tao H et al. | P38 mitogen-activated protein kinase inhibitor, FR167653, inhibits parathyroid hormone related protein-induced osteoclastogenesis and bone resorption. | 2011 | PLoS ONE | pmid:21886782 |
| Persson E and Lerner UH | The neuropeptide VIP regulates the expression of osteoclastogenic factors in osteoblasts. | 2011 | J. Cell. Biochem. | pmid:21815197 |
| Christoforidis A et al. | Comparative study of dual energy X-ray absorptiometry and quantitative ultrasonography with the use of biochemical markers of bone turnover in boys with haemophilia. | 2011 | Haemophilia | pmid:20825502 |
| Grigoropoulou P et al. | The role of the osteoprotegerin/RANKL/RANK system in diabetic vascular disease. | 2011 | Curr. Med. Chem. | pmid:21919846 |
| Riancho JA and Delgado-Calle J | [Osteoblast-osteoclast interaction mechanisms]. | 2011 | Reumatol Clin | pmid:21924211 |
| Peng S et al. | The cross-talk between osteoclasts and osteoblasts in response to strontium treatment: involvement of osteoprotegerin. | 2011 | Bone | pmid:21925296 |
| Fan R et al. | Receptor activator of nuclear factor kappa B ligand and osteoprotegerin expression in chronic apical periodontitis: possible association with inflammatory cells. | 2011 | Chin. Med. J. | pmid:21933620 |
| Osorio A et al. | Mineral-bone metabolism markers in young hemodialysis patients. | 2011 | Clin. Biochem. | pmid:21933667 |
| Nybo M et al. | Rosiglitazone decreases plasma levels of osteoprotegerin in a randomized clinical trial with type 2 diabetes patients. | 2011 | Basic Clin. Pharmacol. Toxicol. | pmid:21726411 |
| Fradet A et al. | Dual function of ERRα in breast cancer and bone metastasis formation: implication of VEGF and osteoprotegerin. | 2011 | Cancer Res. | pmid:21734015 |
| Campbell GM et al. | Bone quality is partially recovered after the discontinuation of RANKL administration in rats by increased bone mass on existing trabeculae: an in vivo micro-CT study. | 2011 | Osteoporos Int | pmid:20480144 |
| Tekkesin MS et al. | The role of RANK/RANKL/OPG signalling pathways in osteoclastogenesis in odontogenic keratocysts, radicular cysts, and ameloblastomas. | 2011 | Head Neck Pathol | pmid:21643971 |
| Jiang JQ et al. | Serum osteoprotegerin measurement for early diagnosis of chronic kidney disease-mineral and bone disorder. | 2011 | Nephrology (Carlton) | pmid:21649792 |
| Choi EM | Honokiol isolated from Magnolia officinalis stimulates osteoblast function and inhibits the release of bone-resorbing mediators. | 2011 | Int. Immunopharmacol. | pmid:21621646 |
| Ueland T et al. | Osteoprotegerin levels predict mortality in patients with symptomatic aortic stenosis. | 2011 | J. Intern. Med. | pmid:21623962 |
| Wheater G et al. | Suppression of bone turnover by B-cell depletion in patients with rheumatoid arthritis. | 2011 | Osteoporos Int | pmid:21625887 |
| Karadag-Saygi E et al. | The effect of risedronate treatment on serum osteoprotegerin and bone marker levels in postmenopausal women with osteoporosis. | 2011 | Gynecol. Endocrinol. | pmid:21627558 |
| Taylor R et al. | Osteoclast formation and function in pigmented villonodular synovitis. | 2011 | J. Pathol. | pmid:21706481 |
| Conaway HH et al. | Retinoids stimulate periosteal bone resorption by enhancing the protein RANKL, a response inhibited by monomeric glucocorticoid receptor. | 2011 | J. Biol. Chem. | pmid:21715325 |
| Kanayama K et al. | Osteoclast and osteoblast activities on carbonate apatite plates in cell cultures. | 2011 | J Biomater Appl | pmid:20624844 |
| Bao L et al. | Anthraquinone compounds from Morinda officinalis inhibit osteoclastic bone resorption in vitro. | 2011 | Chem. Biol. Interact. | pmid:21945525 |
| Zhou XW et al. | [Expressions of RANK, RANKL, and osteoprotegerin in male rats at different ages]. | 2011 | Nan Fang Yi Ke Da Xue Xue Bao | pmid:21945761 |
| Teramachi J et al. | Adenosine abolishes MTX-induced suppression of osteoclastogenesis and inflammatory bone destruction in adjuvant-induced arthritis. | 2011 | Lab. Invest. | pmid:21339747 |
| Carmona-Fernandes D et al. | Soluble receptor activator of nuclear factor κB ligand/osteoprotegerin ratio is increased in systemic lupus erythematosus patients. | 2011 | Arthritis Res. Ther. | pmid:22027240 |
| Katz J et al. | Genetic polymorphisms and other risk factors associated with bisphosphonate induced osteonecrosis of the jaw. | 2011 | Int J Oral Maxillofac Surg | pmid:21396799 |
| Wang Y et al. | [Interleukin-4 and osteoprotegerin suppress polyethylene wear debris-induced osteolysis in a murine air pouch model]. | 2011 | Nan Fang Yi Ke Da Xue Xue Bao | pmid:22027773 |
| Bitto A et al. | Genistein aglycone effect on bone loss is not enhanced by supplemental calcium and vitamin D3: a dose ranging experimental study. | 2011 | Phytomedicine | pmid:21397481 |
| Wang JZ et al. | [Effect of Epimedium extract on osteoprotegerin and RANKL mRNA expressions in glucocorticoid-induced femoral head necrosis in rats]. | 2011 | Nan Fang Yi Ke Da Xue Xue Bao | pmid:22027774 |
| Di Bartolo BA et al. | Calcium and osteoprotegerin regulate IGF1R expression to inhibit vascular calcification. | 2011 | Cardiovasc. Res. | pmid:21447702 |
| Ho TY et al. | Effects of relaxin and estrogens on bone remodeling markers, receptor activator of NF-kB ligand (RANKL) and osteoprotegerin (OPG), in rat adjuvant-induced arthritis. | 2011 | Bone | pmid:21419242 |
| Chasseraud M et al. | Tumor necrosis factor-related apoptosis-inducing ligand and vascular calcification. | 2011 | Ther Apher Dial | pmid:21426505 |
| Duheron V et al. | Receptor activator of NF-kappaB (RANK) stimulates the proliferation of epithelial cells of the epidermo-pilosebaceous unit. | 2011 | Proc. Natl. Acad. Sci. U.S.A. | pmid:21402940 |
| Dimitrow PP et al. | The influence of statins on levels of calcification biomarkers in patients with aortic sclerosis or mild aortic stenosis. | 2011 | J. Heart Valve Dis. | pmid:21404893 |
| Yener S et al. | Is there an association between non-functioning adrenal adenoma and endothelial dysfunction? | 2011 | J. Endocrinol. Invest. | pmid:20530985 |
| Giro G et al. | Influence of estrogen deficiency on bone around osseointegrated dental implants: an experimental study in the rat jaw model. | 2011 | J. Oral Maxillofac. Surg. | pmid:21530046 |
| Won KY et al. | RANK signalling in bone lesions with osteoclast-like giant cells. | 2011 | Pathology | pmid:21532526 |
| Naot D et al. | Molecular mechanisms involved in the mitogenic effect of lactoferrin in osteoblasts. | 2011 | Bone | pmid:21515435 |
| Aydin H et al. | Effect of oxidative stress on aorta and tibia osteoprotegerin gene expression in ovariectomized rats. | 2011 | Minerva Endocrinol. | pmid:21519319 |
| Xu ML et al. | [An update for the research progress of osteoprotegerin on coronary artery disease]. | 2011 | Zhonghua Xin Xue Guan Bing Za Zhi | pmid:22321243 |
| Altinova AE et al. | Relationship between serum osteoprotegerin, glycemic control, renal function and markers of atherosclerosis in type 2 diabetes. | 2011 | Scand. J. Clin. Lab. Invest. | pmid:21486111 |
| Mercatali L et al. | Bone metastases detection by circulating biomarkers: OPG and RANK-L. | 2011 | Int. J. Oncol. | pmid:21491082 |
| Stein SH et al. | Statins regulate interleukin-1β-induced RANKL and osteoprotegerin production by human gingival fibroblasts. | 2011 | J. Periodont. Res. | pmid:21463327 |
| Liang QQ et al. | The expression of osteoprotegerin is required for maintaining the intervertebral disc endplate of aged mice. | 2011 | Bone | pmid:21466864 |
| Kassi E et al. | Effects of Sideritis euboea (Lamiaceae) aqueous extract on IL-6, OPG and RANKL secretion by osteoblasts. | 2011 | Nat Prod Commun | pmid:22224290 |
| Dimitri P et al. | Adipokines, bone-derived factors and bone turnover in obese children; evidence for altered fat-bone signalling resulting in reduced bone mass. | 2011 | Bone | pmid:20932948 |
| Yu H et al. | Overexpression of osteoprotegerin promotes preosteoblast differentiation to mature osteoblasts. | 2011 | Angle Orthod | pmid:20936961 |
| Toffoli B et al. | Osteoprotegerin induces morphological and functional alterations in mouse pancreatic islets. | 2011 | Mol. Cell. Endocrinol. | pmid:20832449 |
| Hou WW et al. | Involvement of Wnt activation in the micromechanical vibration-enhanced osteogenic response of osteoblasts. | 2011 | J Orthop Sci | pmid:21833614 |
| Attia EA et al. | Assessment of osteoporosis in psoriasis with and without arthritis: correlation with disease severity. | 2011 | Int. J. Dermatol. | pmid:21182499 |
| Sun Z and Tee BC | Molecular variations related to the regional differences in periosteal growth at the mandibular ramus. | 2011 | Anat Rec (Hoboken) | pmid:21157918 |
| Cannon JG et al. | Follicle-stimulating hormone promotes RANK expression on human monocytes. | 2011 | Cytokine | pmid:21159522 |
| Choe JY et al. | Radiographic bone damage in chronic gout is negatively associated with the inflammatory cytokines soluble interleukin 6 receptor and osteoprotegerin. | 2011 | J. Rheumatol. | pmid:21159831 |
| Mahoney DJ et al. | TSG-6 inhibits osteoclast activity via an autocrine mechanism and is functionally synergistic with osteoprotegerin. | 2011 | Arthritis Rheum. | pmid:21162099 |
| Čolović M et al. | FGF-R3 and OPG expression in patient with multiple myeloma following systemic sclerosis: case report and review of the literature. | 2011 | Int. J. Hematol. | pmid:21207214 |
| Jørgensen L et al. | Serum osteoprotegerin levels are related to height loss: the Tromsø Study. | 2011 | Eur. J. Epidemiol. | pmid:21331661 |
| Yuan H et al. | Receptor activator of nuclear factor kappa B ligand antagonists inhibit tissue inflammation and bone loss in experimental periodontitis. | 2011 | J. Clin. Periodontol. | pmid:22092474 |
| Garcia VG et al. | Treatment of experimental periodontal disease with antimicrobial photodynamic therapy in nicotine-modified rats. | 2011 | J. Clin. Periodontol. | pmid:22092666 |
| Hen K et al. | [Osteoprotegerin--a new atherosclerosis marker]. | 2011 | Pol. Merkur. Lekarski | pmid:22097184 |
| Tang Y et al. | Porphyromonas endodontalis lipopolysaccharides induce RANKL by mouse osteoblast in a way different from that of Escherichia coli lipopolysaccharide. | 2011 | J Endod | pmid:22099899 |
| Kuczkowski J et al. | Expression of the receptor activator for nuclear factor-κB ligand and osteoprotegerin in chronic otitis media. | 2010 Nov-Dec | Am J Otolaryngol | pmid:20015790 |
| Kuczkowski J et al. | [Molecular control of bone resorption in chronic otitis media with cholesteatoma]. | 2010 Jul-Aug | Otolaryngol Pol | pmid:20873097 |
| Reyes-GarcÃa R et al. | Effects of alendronate treatment on serum levels of osteoprotegerin and total receptor activator of nuclear factor kappaB in women with postmenopausal osteoporosis. | 2010 Jan-Feb | Menopause | pmid:19574937 |
| Mori K et al. | Effects of pravastatin on serum osteoprotegerin levels in patients with hypercholesterolemia and type 2 diabetes. | 2010 Feb-Mar | Angiology | pmid:19147525 |
| Noheria A et al. | Association of serum osteoprotegerin with left ventricular mass in African American adults with hypertension. | 2010 | Am. J. Hypertens. | pmid:20339356 |
| Mogi M and Kondo A | ELISA for RANKL-OPG complex in mouse sera. | 2010 | J Immunoassay Immunochem | pmid:20391022 |
| Schramm HM | The role of the osteoimmune axis in the inflammation of the inner auditory ear and with regard to the putative anticarcinogenetic principle: part 2. | 2010 | Inflamm Allergy Drug Targets | pmid:20402646 |
| Fanourakis G et al. | Expression of receptor activator of NF-κB ligand and osteoprotegerin in peripheral giant cell granulomas of the jaws. | 2010 | J. Oral Pathol. Med. | pmid:20701665 |
| Zupan J et al. | Gene-gene interactions in RANK/RANKL/OPG system influence bone mineral density in postmenopausal women. | 2010 | J. Steroid Biochem. Mol. Biol. | pmid:19896533 |
| Le Heron L et al. | Cystic fibrosis transmembrane conductance regulator (CFTR) regulates the production of osteoprotegerin (OPG) and prostaglandin (PG) E2 in human bone. | 2010 | J. Cyst. Fibros. | pmid:20005786 |
| Lossdörfer S et al. | Aging affects the phenotypic characteristics of human periodontal ligament cells and the cellular response to hormonal stimulation in vitro. | 2010 | J. Periodont. Res. | pmid:20682014 |
| Ostrowski MC | A new role for OPG: putting RANKL in its place. | 2010 | J. Bone Miner. Res. | pmid:20684024 |
| Qian Y and Huang HZ | The role of RANKL and MMP-9 in the bone resorption caused by ameloblastoma. | 2010 | J. Oral Pathol. Med. | pmid:20412401 |
| Qian H et al. | Activation of cannabinoid receptor CB2 regulates osteogenic and osteoclastogenic gene expression in human periodontal ligament cells. | 2010 | J. Periodont. Res. | pmid:20412420 |
| Eagan TM et al. | Body composition and plasma levels of inflammatory biomarkers in COPD. | 2010 | Eur. Respir. J. | pmid:20413541 |
| Lamoureux F et al. | Regulation of osteoprotegerin pro- or anti-tumoral activity by bone tumor microenvironment. | 2010 | Biochim. Biophys. Acta | pmid:19733222 |
| Mine Y et al. | Impact of titanium ions on osteoblast-, osteoclast- and gingival epithelial-like cells. | 2010 | J Prosthodont Res | pmid:19733525 |
| Odiere MR et al. | Protein deficiency and nematode infection during pregnancy and lactation reduce maternal bone mineralization and neonatal linear growth in mice. | 2010 | J. Nutr. | pmid:20660285 |
| Saito-Yabe M et al. | PEGylation of osteoprotegerin/osteoclastogenesis inhibitory factor (OPG/OCIF) results in decreased uptake into rats and human liver. | 2010 | J. Pharm. Pharmacol. | pmid:20663032 |
| Wagner H | Bone diseases: Interferon regulatory factor-8 suppresses osteoclastogenesis. | 2010 | Nat Rev Rheumatol | pmid:20125173 |
| Jiang XY et al. | Association of LPR5 polymorphism with bone mass density and cholesterol level in population of Chinese Han. | 2010 | Exp. Clin. Endocrinol. Diabetes | pmid:20146170 |
| Stankovic KM et al. | Differences in gene expression between the otic capsule and other bones. | 2010 | Hear. Res. | pmid:20146935 |
| Daoussis D et al. | Wnt pathway and IL-17: novel regulators of joint remodeling in rheumatic diseases. Looking beyond the RANK-RANKL-OPG axis. | 2010 | Semin. Arthritis Rheum. | pmid:19095294 |
| Ruiz-Gaspà S et al. | Lithocholic acid downregulates vitamin D effects in human osteoblasts. | 2010 | Eur. J. Clin. Invest. | pmid:20055894 |
| Sypniewska G et al. | Does serum osteoprotegerin level relate to fragility fracture in elderly women with low vitamin D status? | 2010 | Med. Sci. Monit. | pmid:20110921 |
| Subramaniam M et al. | TGFbeta inducible early gene-1 directly binds to, and represses, the OPG promoter in osteoblasts. | 2010 | Biochem. Biophys. Res. Commun. | pmid:20059964 |
| Norazlina M et al. | Effects of vitamin E on receptor activator of nuclear factor kappa B ligand (RANKL) and osteoprotegerin (OPG) in rats treated with nicotine. | 2010 | Med. J. Malaysia | pmid:21265240 |
| Kenanidis EI et al. | Serum levels of bone turnover markers following total joint arthroplasty. | 2010 | J Orthop Surg (Hong Kong) | pmid:21187538 |